Healthcare Sector Stocks
The Healthcare sector has a total of 1048 stocks, with a combined market cap of $10.04 trillion, total revenue of $4.74 trillion and a weighted average PE ratio of 47.17.
Market Cap
10.04T
Revenue
4.74T
Profits
212.89B
PE Ratio
47.17
Profit Margin
4.49%
Dividend Yield
0.37%
1047 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.26T | 0.28% | 491,688 | 86.46B |
| 2 | JNJ | Johnson & Johnson | 676.19B | -0.43% | 1,212,758 | 99.34B |
| 3 | ABBV | AbbVie Inc. | 517.37B | -0.21% | 899,913 | 66.01B |
| 4 | MRK | Merck & Co., Inc. | 360.42B | -1.72% | 1,387,368 | 67.38B |
| 5 | UNH | UnitedHealth Group Incorporated | 357.54B | 0.35% | 833,645 | 450.06B |
| 6 | NVS | Novartis AG | 305.90B | -0.32% | 331,865 | 57.36B |
| 7 | AZN | AstraZeneca PLC | 288.77B | -1.33% | 474,009 | 62.38B |
| 8 | TMO | Thermo Fisher Scientific Inc. | 265.82B | -0.58% | 308,549 | 47.35B |
| 9 | AMGN | Amgen Inc. | 250.63B | -0.40% | 217,229 | 38.90B |
| 10 | GILD | Gilead Sciences, Inc. | 209.83B | -0.09% | 625,990 | 30.99B |
| 11 | ABT | Abbott Laboratories | 188.97B | -1.27% | 692,325 | 48.23B |
| 12 | NVO | Novo Nordisk A/S | 176.86B | -1.99% | 1,603,880 | 50.70B |
| 13 | PFE | Pfizer Inc. | 165.95B | -0.39% | 6,290,018 | 63.62B |
| 14 | DHR | Danaher Corporation | 164.92B | -0.30% | 1,401,818 | 25.61B |
| 15 | ISRG | Intuitive Surgical, Inc. | 155.85B | -2.38% | 245,341 | 11.58B |
| 16 | VRTX | Vertex Pharmaceuticals Incorporated | 138.68B | -0.71% | 153,296 | 12.95B |
| 17 | BMY | Bristol-Myers Squibb Company | 126.18B | -0.66% | 1,117,262 | 50.03B |
| 18 | MDT | Medtronic plc | 124.01B | -1.45% | 678,926 | 37.54B |
| 19 | MCK | McKesson Corporation | 123.19B | 0.72% | 66,487 | 418.79B |
| 20 | SYK | Stryker Corporation | 121.74B | -1.82% | 473,365 | 26.30B |
| 21 | SNY | Sanofi | 114.56B | -0.48% | 716,733 | 57.89B |
| 22 | CVS | CVS Health Corporation | 110.28B | 1.11% | 4,279,392 | 418.16B |
| 23 | HCA | HCA Healthcare, Inc. | 105.16B | -0.30% | 133,886 | 78.70B |
| 24 | MRNA | Moderna, Inc. | 104.74B | -3.77% | 3,734,441 | 2.53B |
| 25 | GSK | GSK plc | 102.14B | -0.28% | 521,892 | 44.53B |
| 26 | REGN | Regeneron Pharmaceuticals, Inc. | 91.47B | -0.92% | 87,037 | 16.90B |
| 27 | ELV | Elevance Health, Inc. | 90.44B | 0.09% | 71,035 | 201.83B |
| 28 | CI | The Cigna Group | 78.03B | 0.18% | 106,187 | 286.32B |
| 29 | COR | Cencora, Inc. | 65.84B | -0.22% | 110,903 | 337.40B |
| 30 | TAK | Takeda Pharmaceutical Company Limited | 65.74B | -1.35% | 489,385 | 29.86B |
| 31 | BSX | Boston Scientific Corporation | 63.43B | -0.59% | 2,204,646 | 21.07B |
| 32 | CAH | Cardinal Health, Inc. | 63.25B | -0.23% | 147,930 | 257.75B |
| 33 | ARGX | argenx SE | 59.92B | 0.17% | 94,757 | 5.92B |
| 34 | EW | Edwards Lifesciences Corporation | 59.04B | -1.95% | 406,900 | 6.67B |
| 35 | BDX | Becton, Dickinson and Company | 57.95B | -1.16% | 224,493 | 19.46B |
| 36 | IDXX | IDEXX Laboratories, Inc. | 54.03B | -2.95% | 88,679 | 4.66B |
| 37 | MDLN | Medline Inc. | 53.13B | -0.79% | 1,180,301 | 30.68B |
| 38 | HUM | Humana Inc. | 51.13B | 0.58% | 98,716 | 154.19B |
| 39 | A | Agilent Technologies, Inc. | 50.14B | -1.28% | 939,251 | 7.37B |
| 40 | TEVA | Teva Pharmaceutical Industries Limited | 49.30B | -1.68% | 897,227 | 17.23B |
| 41 | VEEV | Veeva Systems Inc. | 49.14B | -0.95% | 202,290 | 3.46B |
| 42 | ONC | BeOne Medicines AG | 47.87B | 0.41% | 143,011 | 6.45B |
| 43 | WAT | Waters Corporation | 46.30B | -1.14% | 51,859 | 5.61B |
| 44 | NTRA | Natera, Inc. | 46.03B | -0.93% | 656,178 | 2.91B |
| 45 | IQV | IQVIA Holdings Inc. | 45.28B | -1.47% | 120,703 | 17.31B |
| 46 | RVMD | Revolution Medicines, Inc. | 42.28B | -2.33% | 339,633 | 197.56M |
| 47 | HLN | Haleon plc | 39.34B | 0.84% | 3,836,305 | 14.80B |
| 48 | RPRX | Royalty Pharma plc | 38.92B | -1.32% | 401,830 | 2.62B |
| 49 | GEHC | GE HealthCare Technologies Inc. | 37.39B | -1.58% | 260,564 | 21.64B |
| 50 | BIIB | Biogen Inc. | 37.27B | -1.07% | 121,096 | 10.30B |
| 51 | ALC | Alcon Inc. | 36.03B | -0.01% | 422,816 | 10.86B |
| 52 | MTD | Mettler-Toledo International Inc. | 34.68B | -1.07% | 13,802 | 4.20B |
| 53 | GMAB | Genmab A/S | 33.65B | -3.10% | 914,107 | 4.30B |
| 54 | CNC | Centene Corporation | 33.54B | -1.17% | 718,599 | 180.41B |
| 55 | ILMN | Illumina, Inc. | 33.19B | -0.58% | 234,190 | 4.54B |
| 56 | ZTS | Zoetis Inc. | 32.92B | -1.58% | 511,694 | 9.49B |
| 57 | RMD | ResMed Inc. | 32.74B | -1.27% | 174,125 | 5.73B |
| 58 | DXCM | DexCom, Inc. | 29.77B | -1.54% | 403,339 | 5.10B |
| 59 | LH | Labcorp Holdings Inc. | 29.61B | -1.92% | 82,314 | 14.59B |
| 60 | PHG | Koninklijke Philips N.V. | 29.49B | -1.38% | 230,249 | 20.16B |
| 61 | ROIV | Roivant Sciences Ltd. | 29.30B | -0.57% | 2,014,131 | 41.08M |
| 62 | WST | West Pharmaceutical Services, Inc. | 28.81B | 0.16% | 56,243 | 3.40B |
| 63 | DGX | Quest Diagnostics Incorporated | 28.08B | -1.72% | 70,662 | 11.84B |
| 64 | INSM | Insmed Incorporated | 25.77B | 1.16% | 530,611 | 1.52B |
| 65 | UTHR | United Therapeutics Corporation | 24.83B | 0.11% | 75,078 | 3.19B |
| 66 | STE | STERIS plc | 24.58B | -1.48% | 96,446 | 6.17B |
| 67 | INCY | Incyte Corporation | 24.57B | -1.12% | 157,797 | 6.01B |
| 68 | VTRS | Viatris Inc. | 23.41B | -0.34% | 1,111,408 | 14.73B |
| 69 | THC | Tenet Healthcare Corporation | 22.90B | -0.45% | 88,404 | 22.15B |
| 70 | BNTX | BioNTech SE | 21.69B | -0.03% | 136,837 | 2.75B |
| 71 | GH | Guardant Health, Inc. | 21.51B | 0.13% | 516,076 | 1.28B |
| 72 | ZBH | Zimmer Biomet Holdings, Inc. | 20.50B | -0.03% | 268,402 | 8.57B |
| 73 | ALNY | Alnylam Pharmaceuticals, Inc. | 20.49B | -2.31% | 361,299 | 5.01B |
| 74 | MEDP | Medpace Holdings, Inc. | 18.67B | -0.82% | 31,564 | 2.84B |
| 75 | RVTY | Revvity, Inc. | 17.69B | -1.34% | 171,864 | 2.94B |
| 76 | EXEL | Exelixis, Inc. | 17.15B | -2.01% | 402,308 | 2.50B |
| 77 | ASND | Ascendis Pharma A/S | 16.98B | -0.48% | 66,298 | 1.20B |
| 78 | NBIX | Neurocrine Biosciences, Inc. | 16.92B | -0.99% | 109,179 | 3.70B |
| 79 | CRL | Charles River Laboratories International, Inc. | 16.53B | -2.39% | 170,083 | 3.98B |
| 80 | JAZZ | Jazz Pharmaceuticals plc | 15.52B | -0.69% | 58,293 | 4.72B |
| 81 | BBIO | BridgeBio Pharma, Inc. | 15.43B | 1.65% | 368,957 | 945.54M |
| 82 | ICLR | ICON Public Limited Company | 15.08B | -3.05% | 78,386 | 8.23B |
| 83 | SOLV | Solventum Corporation | 15.06B | -1.91% | 92,688 | 8.16B |
| 84 | TEM | Tempus AI, Inc. | 14.94B | -3.03% | 1,398,732 | 1.51B |
| 85 | BTSG | BrightSpring Health Services, Inc. | 14.41B | 0.01% | 326,446 | 15.25B |
| 86 | SMMT | Summit Therapeutics Inc. | 14.29B | 0.17% | 1,088,641 | - |
| 87 | GKOS | Glaukos Corporation | 14.08B | -0.33% | 67,055 | 690.33M |
| 88 | EHC | Encompass Health Corporation | 13.85B | -0.01% | 153,663 | 6.34B |
| 89 | ELAN | Elanco Animal Health Incorporated | 13.32B | -0.75% | 526,224 | 5.15B |
| 90 | BAX | Baxter International Inc. | 13.31B | -2.61% | 517,473 | 11.61B |
| 91 | PEN | Penumbra, Inc. | 12.64B | -0.34% | 50,545 | 1.56B |
| 92 | SNN | Smith & Nephew plc | 12.63B | -1.35% | 422,358 | 6.30B |
| 93 | RDY | Dr. Reddy's Laboratories Limited | 12.22B | -0.73% | 181,001 | 3.44B |
| 94 | ALGN | Align Technology, Inc. | 12.21B | -0.63% | 163,432 | 4.16B |
| 95 | COO | The Cooper Companies, Inc. | 11.99B | -1.33% | 261,371 | 4.24B |
| 96 | HALO | Halozyme Therapeutics, Inc. | 11.89B | 1.32% | 401,269 | 1.80B |
| 97 | KYMR | Kymera Therapeutics, Inc. | 11.87B | 0.16% | 147,598 | 102.24M |
| 98 | FMS | Fresenius Medical Care AG | 11.80B | -0.92% | 273,600 | 22.12B |
| 99 | DVA | DaVita Inc. | 11.47B | -1.73% | 177,236 | 14.17B |
| 100 | TECH | Bio-Techne Corporation | 11.44B | -0.03% | 441,023 | 1.23B |
| 101 | RGEN | Repligen Corporation | 11.30B | -1.19% | 102,591 | 805.61M |
| 102 | UHS | Universal Health Services, Inc. | 11.28B | -0.81% | 56,195 | 18.35B |
| 103 | BMRN | BioMarin Pharmaceutical Inc. | 10.94B | -1.19% | 153,064 | 3.66B |
| 104 | PCVX | Vaxcyte, Inc. | 10.64B | -0.44% | 267,829 | - |
| 105 | ENSG | The Ensign Group, Inc. | 10.62B | 0.80% | 40,836 | 5.67B |
| 106 | AVTR | Avantor, Inc. | 10.57B | -1.98% | 641,463 | 6.64B |
| 107 | MOH | Molina Healthcare, Inc. | 10.56B | -0.34% | 60,806 | 42.08B |
| 108 | QGEN | Qiagen N.V. | 10.42B | -0.16% | 902,634 | 2.12B |
| 109 | BIO | Bio-Rad Laboratories, Inc. | 10.33B | -1.11% | 25,793 | 2.59B |
| 110 | PODD | Insulet Corporation | 10.23B | -1.54% | 106,839 | 3.19B |
| 111 | SYRE | Spyre Therapeutics, Inc. | 10.10B | -2.45% | 158,865 | - |
| 112 | OSCR | Oscar Health, Inc. | 10.06B | 0.84% | 682,881 | 17.47B |
| 113 | MDGL | Madrigal Pharmaceuticals, Inc. | 10.04B | -0.18% | 125,396 | 1.43B |
| 114 | GMED | Globus Medical, Inc. | 9.93B | -1.89% | 269,977 | 3.14B |
| 115 | BRKR | Bruker Corporation | 9.84B | -3.19% | 313,453 | 3.51B |
| 116 | HSIC | Henry Schein, Inc. | 9.76B | -0.17% | 76,835 | 13.73B |
| 117 | HNGE | Hinge Health, Inc. | 9.72B | -1.46% | 147,773 | 800.82M |
| 118 | TGTX | TG Therapeutics, Inc. | 9.39B | 4.45% | 1,027,989 | 897.76M |
| 119 | PRAX | Praxis Precision Medicines, Inc. | 9.33B | 0.39% | 84,675 | 7.46M |
| 120 | ATR | AptarGroup, Inc. | 9.04B | -1.09% | 53,833 | 3.99B |
| 121 | KRYS | Krystal Biotech, Inc. | 9.00B | 0.17% | 27,425 | 470.03M |
| 122 | PTGX | Protagonist Therapeutics, Inc. | 8.87B | -0.01% | 66,025 | 551.69M |
| 123 | TXG | 10x Genomics, Inc. | 8.55B | -0.06% | 646,806 | 618.58M |
| 124 | TWST | Twist Bioscience Corporation | 8.53B | 0.45% | 367,863 | 431.80M |
| 125 | HQY | HealthEquity, Inc. | 8.37B | -0.84% | 41,687 | 1.36B |
| 126 | CORT | Corcept Therapeutics Incorporated | 8.19B | -0.21% | 96,831 | 963.65M |
| 127 | ABVX | ABIVAX Société Anonyme | 7.87B | 3.68% | 277,798 | 5.33M |
| 128 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.83B | -0.84% | 80,213 | 280.75M |
| 129 | PACS | PACS Group, Inc. | 7.75B | 0.06% | 56,914 | 5.71B |
| 130 | CYTK | Cytokinetics, Incorporated | 7.70B | 0.29% | 486,312 | 113.29M |
| 131 | ALKS | Alkermes plc | 7.65B | -1.34% | 112,666 | 1.75B |
| 132 | GRFS | Grifols, S.A. | 7.57B | -0.52% | 63,665 | 8.63B |
| 133 | IBRX | ImmunityBio, Inc. | 7.49B | -0.98% | 5,229,574 | 182.57M |
| 134 | KNSA | Kiniksa Pharmaceuticals International, plc | 7.49B | -3.50% | 69,212 | 945.96M |
| 135 | BLCO | Bausch + Lomb Corporation | 7.48B | -0.24% | 151,935 | 5.42B |
| 136 | IMVT | Immunovant, Inc. | 7.41B | 1.91% | 181,341 | - |
| 137 | AMRX | Amneal Pharmaceuticals, Inc. | 7.39B | -0.33% | 270,712 | 3.20B |
| 138 | AXSM | Axsome Therapeutics, Inc. | 7.34B | 4.20% | 366,184 | 865.27M |
| 139 | CAI | Caris Life Sciences, Inc. | 7.14B | -2.70% | 661,748 | 1.05B |
| 140 | CHE | Chemed Corporation | 6.96B | -0.17% | 15,869 | 2.66B |
| 141 | ARWR | Arrowhead Pharmaceuticals, Inc. | 6.95B | -0.14% | 448,276 | 669.50M |
| 142 | ORKA | Oruka Therapeutics, Inc. | 6.91B | -0.22% | 149,099 | - |
| 143 | KOD | Kodiak Sciences Inc. | 6.67B | -0.72% | 165,883 | - |
| 144 | LNTH | Lantheus Holdings, Inc. | 6.64B | 0.45% | 172,420 | 1.56B |
| 145 | CGON | CG Oncology, Inc. | 6.56B | -1.73% | 154,325 | 6.17M |
| 146 | BLTE | Belite Bio, Inc | 6.42B | 1.05% | 27,968 | - |
| 147 | LGND | Ligand Pharmaceuticals Incorporated | 6.31B | 0.35% | 37,156 | 253.83M |
| 148 | MANE | Veradermics, Incorporated | 6.13B | 1.99% | 171,836 | - |
| 149 | RDNT | RadNet, Inc. | 6.12B | -0.93% | 93,326 | 2.38B |
| 150 | TFX | Teleflex Incorporated | 6.11B | -0.43% | 73,981 | 2.26B |
| 151 | MIRM | Mirum Pharmaceuticals, Inc. | 6.05B | -0.54% | 103,484 | 670.78M |
| 152 | SRRK | Scholar Rock Holding Corporation | 5.95B | -5.22% | 355,533 | 570.00K |
| 153 | DOCS | Doximity, Inc. | 5.76B | -1.78% | 430,128 | 661.58M |
| 154 | COGT | Cogent Biosciences, Inc. | 5.75B | -1.43% | 160,509 | - |
| 155 | SUPN | Supernus, Inc. | 5.72B | -0.22% | 420,161 | 1.37B |
| 156 | LFST | LifeStance Health Group, Inc. | 5.64B | 1.68% | 5,452,304 | 1.68B |
| 157 | GRAL | GRAIL, Inc. | 5.63B | -2.30% | 136,578 | 166.60M |
| 158 | WAY | Waystar Holding Corp. | 5.52B | -1.61% | 117,755 | 1.26B |
| 159 | HAE | Haemonetics Corporation | 5.39B | 0.06% | 50,206 | 1.38B |
| 160 | PTCT | PTC Therapeutics, Inc. | 5.38B | -0.97% | 57,952 | 1.16B |
| 161 | ERAS | Erasca, Inc. | 5.33B | -2.37% | 1,234,023 | - |
| 162 | CON | Concentra Group Holdings Parent, Inc. | 5.32B | -0.80% | 128,188 | 2.34B |
| 163 | MMSI | Merit Medical Systems, Inc. | 5.23B | -1.28% | 91,533 | 1.61B |
| 164 | BLLN | BillionToOne, Inc. | 5.20B | -5.26% | 288,358 | 436.87M |
| 165 | EWTX | Edgewise Therapeutics, Inc. | 5.03B | -5.77% | 484,810 | - |
| 166 | DNTH | Dianthus Therapeutics, Inc. | 5.00B | -1.39% | 65,271 | 2.72M |
| 167 | LIVN | LivaNova PLC | 4.95B | -2.89% | 74,344 | 1.51B |
| 168 | MMED | MiniMed Group, Inc. | 4.91B | -2.35% | 1,041,239 | 3.22B |
| 169 | ADPT | Adaptive Biotechnologies Corporation | 4.89B | -0.17% | 314,746 | 298.01M |
| 170 | HTFL | HeartFlow, Inc. | 4.86B | -1.27% | 237,376 | 212.07M |
| 171 | TVTX | Travere Therapeutics, Inc. | 4.85B | -2.19% | 140,628 | 651.03M |
| 172 | IONS | Ionis Pharmaceuticals, Inc. | 4.81B | -6.84% | 1,319,122 | 960.09M |
| 173 | OPCH | Option Care Health, Inc. | 4.74B | -0.16% | 181,353 | 5.75B |
| 174 | DFTX | Definium Therapeutics, Inc. | 4.68B | -1.64% | 202,254 | - |
| 175 | SHC | Sotera Health Company | 4.64B | -1.22% | 279,571 | 1.23B |
| 176 | HIMS | Hims & Hers Health, Inc. | 4.63B | -13.82% | 22,761,785 | 2.87B |
| 177 | CRSP | CRISPR Therapeutics AG | 4.61B | -5.08% | 514,696 | 25.17M |
| 178 | ICUI | ICU Medical, Inc. | 4.51B | 0.72% | 38,839 | 2.18B |
| 179 | RLAY | Relay Therapeutics, Inc. | 4.43B | -1.77% | 412,104 | 10.35M |
| 180 | CDNA | CareDx, Inc. | 4.35B | -1.98% | 179,702 | 497.40M |
| 181 | ITGR | Integer Holdings Corporation | 4.30B | - | 68,112 | 1.83B |
| 182 | LQDA | Liquidia Corporation | 4.27B | -0.36% | 786,385 | 621.87M |
| 183 | LEGN | Legend Biotech Corporation | 4.12B | -12.52% | 1,613,580 | 1.36B |
| 184 | NVST | Envista Holdings Corporation | 4.09B | -1.81% | 152,128 | 2.88B |
| 185 | ABCL | AbCellera Biologics Inc. | 4.00B | -1.20% | 1,213,566 | 67.85M |
| 186 | TNGX | Tango Therapeutics, Inc. | 3.99B | 3.61% | 948,196 | 53.81M |
| 187 | PLSE | Pulse Biosciences, Inc. | 3.99B | -6.81% | 85,698 | 1.49M |
| 188 | XENE | Xenon Pharmaceuticals Inc. | 3.92B | 0.16% | 552,688 | 7.50M |
| 189 | AMLX | Amylyx Pharmaceuticals, Inc. | 3.91B | 0.73% | 294,439 | -665.00K |
| 190 | IOVA | Iovance Biotherapeutics, Inc. | 3.83B | 1.41% | 2,648,723 | 378.98M |
| 191 | PBLS | Parabilis Medicines, Inc. | 3.81B | 1.48% | 91,182 | 148.00K |
| 192 | VKTX | Viking Therapeutics, Inc. | 3.79B | 2.52% | 931,010 | - |
| 193 | WRBY | Warby Parker Inc. | 3.76B | 0.07% | 1,006,628 | 934.66M |
| 194 | IRON | Disc Medicine, Inc. | 3.74B | 1.07% | 67,522 | - |
| 195 | ELVN | Enliven Therapeutics, Inc. | 3.72B | -1.98% | 149,859 | - |
| 196 | STVN | Stevanato Group S.p.A. | 3.69B | -1.68% | 54,088 | 1.42B |
| 197 | OGN | Organon & Co. | 3.63B | -0.11% | 308,994 | 6.10B |
| 198 | TARS | Tarsus Pharmaceuticals, Inc. | 3.56B | 1.92% | 48,450 | 682.20M |
| 199 | ACHC | Acadia Healthcare Company, Inc. | 3.56B | -0.91% | 277,319 | 3.41B |
| 200 | SGRY | Surgery Partners, Inc. | 3.45B | 0.53% | 728,346 | 3.36B |
| 201 | VRDN | Viridian Therapeutics, Inc. | 3.44B | 0.30% | 555,952 | 26.31M |
| 202 | ARQT | Arcutis Biotherapeutics, Inc. | 3.41B | 2.86% | 245,290 | 508.68M |
| 203 | CELC | Celcuity Inc. | 3.40B | -1.55% | 95,011 | - |
| 204 | DYN | Dyne Therapeutics, Inc. | 3.38B | -3.01% | 430,582 | - |
| 205 | DNLI | Denali Therapeutics Inc. | 3.24B | -0.54% | 148,388 | 21.38M |
| 206 | NHC | National HealthCare Corporation | 3.23B | -1.72% | 17,473 | 1.58B |
| 207 | TMDX | TransMedics Group, Inc. | 3.19B | -2.23% | 423,558 | 727.65M |
| 208 | TLX | Telix Pharmaceuticals Limited | 3.10B | -4.13% | 56,494 | 890.79M |
| 209 | IDYA | IDEAYA Biosciences, Inc. | 3.09B | -0.37% | 94,296 | 36.54M |
| 210 | BHC | Bausch Health Companies Inc. | 3.06B | -2.80% | 333,247 | 11.11B |
| 211 | GRDN | Guardian Pharmacy Services, Inc. | 3.04B | 2.02% | 100,250 | 1.46B |
| 212 | PRVA | Privia Health Group, Inc. | 3.03B | -3.34% | 109,219 | 2.43B |
| 213 | VCEL | Vericel Corporation | 3.02B | 1.40% | 156,220 | 324.17M |
| 214 | AXGN | Axogen, Inc. | 3.02B | -0.24% | 188,200 | 266.93M |
| 215 | ACAD | Acadia Pharmaceuticals Inc. | 2.99B | 4.91% | 1,618,204 | 1.20B |
| 216 | ZLAB | Zai Lab Limited | 2.99B | -1.12% | 496,206 | 441.73M |
| 217 | XNCR | Xencor, Inc. | 2.95B | 1.79% | 263,281 | 200.49M |
| 218 | IRTC | iRhythm Holdings, Inc. | 2.89B | -3.08% | 149,346 | 854.04M |
| 219 | ATRC | AtriCure, Inc. | 2.88B | -2.02% | 128,453 | 589.80M |
| 220 | XERS | Xeris Biopharma Holdings, Inc. | 2.86B | -1.39% | 767,885 | 368.26M |
| 221 | ADMA | ADMA Biologics, Inc. | 2.84B | 0.04% | 661,532 | 519.15M |
| 222 | AVAH | Aveanna Healthcare Holdings Inc. | 2.83B | -1.67% | 108,053 | 2.60B |
| 223 | RGC | Regencell Bioscience Holdings Limited | 2.73B | -1.96% | 25,131 | - |
| 224 | MBX | MBX Biosciences, Inc. | 2.71B | 4.24% | 135,827 | - |
| 225 | RCUS | Arcus Biosciences, Inc. | 2.68B | -1.69% | 172,852 | 100.00M |
| 226 | HCM | HUTCHMED (China) Limited | 2.67B | 0.52% | 1,969 | 549.12M |
| 227 | CLOV | Clover Health Investments, Corp. | 2.61B | 1.04% | 770,286 | 2.74B |
| 228 | PGNY | Progyny, Inc. | 2.60B | -1.67% | 174,947 | 1.34B |
| 229 | NEOG | Neogen Corporation | 2.57B | -2.48% | 228,275 | 884.00M |
| 230 | BEAM | Beam Therapeutics Inc. | 2.51B | -6.81% | 533,818 | 146.64M |
| 231 | SDGR | Schrödinger, Inc. | 2.48B | -0.90% | 447,570 | 269.20M |
| 232 | ARDT | Ardent Health, Inc. | 2.47B | -2.28% | 122,483 | 6.45B |
| 233 | CLDX | Celldex Therapeutics, Inc. | 2.45B | -0.06% | 147,413 | 158.00K |
| 234 | UFPT | UFP Technologies, Inc. | 2.42B | -1.99% | 10,305 | 649.52M |
| 235 | PVLA | Palvella Therapeutics, Inc. | 2.42B | -5.07% | 89,411 | - |
| 236 | PHVS | Pharvaris N.V. | 2.41B | -0.57% | 69,813 | - |
| 237 | SEPN | Septerna, Inc. | 2.36B | -0.29% | 96,293 | 96.27M |
| 238 | MD | Pediatrix Medical Group, Inc. | 2.36B | -1.68% | 40,693 | 1.96B |
| 239 | NAMS | NewAmsterdam Pharma Company N.V. | 2.36B | 3.37% | 534,931 | 25.94M |
| 240 | RXRX | Recursion Pharmaceuticals, Inc. | 2.29B | -3.42% | 3,627,465 | 68.23M |
| 241 | VIR | Vir Biotechnology, Inc. | 2.29B | -2.16% | 303,093 | 302.80M |
| 242 | PRGO | Perrigo Company plc | 2.29B | -2.83% | 222,087 | 4.09B |
| 243 | BHVN | Biohaven Ltd. | 2.26B | -1.90% | 203,964 | - |
| 244 | NEO | NeoGenomics, Inc. | 2.26B | -0.91% | 112,432 | 787.75M |
| 245 | ADUS | Addus HomeCare Corporation | 2.22B | -0.46% | 26,943 | 1.50B |
| 246 | IMNM | Immunome, Inc. | 2.22B | -3.10% | 228,624 | 4.02M |
| 247 | ZYME | Zymeworks Inc. | 2.21B | 1.01% | 349,403 | 265.97M |
| 248 | AUPH | Aurinia Pharmaceuticals Inc. | 2.21B | -0.96% | 76,366 | 321.74M |
| 249 | TRAX | First Tracks Biotherapeutics, Inc. | 2.19B | 4.75% | 357,683 | - |
| 250 | ALMR | Alamar Biosciences, Inc. | 2.18B | -1.44% | 69,370 | 114.05M |
| 251 | VERA | Vera Therapeutics, Inc. | 2.18B | -1.67% | 284,516 | 10.28M |
| 252 | REPL | Replimune Group, Inc. | 2.14B | 1.53% | 438,696 | - |
| 253 | BKD | Brookdale Senior Living Inc. | 2.13B | -4.62% | 1,978,352 | 2.86B |
| 254 | LKFT | Lakefront Biotherapeutics NV | 2.11B | -1.34% | 88,243 | 1.13B |
| 255 | TRLV | Trulieve Cannabis Corp. | 2.11B | -0.41% | 110,161 | 1.08B |
| 256 | TRVI | Trevi Therapeutics, Inc. | 2.07B | -5.09% | 663,075 | - |
| 257 | PBH | Prestige Consumer Healthcare Inc. | 2.07B | -0.09% | 20,371 | 1.17B |
| 258 | VCYT | Veracyte, Inc. | 2.06B | -1.39% | 432,879 | 581.78M |
| 259 | FTRE | Fortrea Holdings Inc. | 2.06B | -4.18% | 142,452 | 2.67B |
| 260 | MRVI | Maravai LifeSciences Holdings, Inc. | 2.02B | -3.30% | 212,268 | 213.00M |
| 261 | ESTA | Establishment Labs Holdings Inc. | 2.01B | -1.63% | 55,640 | 264.03M |
| 262 | ZBIO | Zenas BioPharma, Inc. | 1.98B | 2.28% | 27,351 | 11.00M |
| 263 | HRMY | Harmony Biosciences Holdings, Inc. | 1.97B | -0.86% | 83,736 | 989.36M |
| 264 | BCRX | BioCryst Pharmaceuticals, Inc. | 1.95B | -0.92% | 399,806 | 961.51M |
| 265 | COAG | Hemab Therapeutics Holdings, Inc. | 1.92B | -4.11% | 140,975 | - |
| 266 | ETON | Eton Pharmaceuticals, Inc. | 1.90B | 2.63% | 295,733 | 141.06M |
| 267 | MAZE | Maze Therapeutics, Inc. | 1.90B | 0.66% | 28,518 | 20.00M |
| 268 | KLRA | Kailera Therapeutics, Inc. | 1.88B | 5.84% | 251,321 | - |
| 269 | AGL | agilon health, inc. | 1.87B | -2.14% | 26,022 | 6.00B |
| 270 | AGIO | Agios Pharmaceuticals, Inc. | 1.86B | -0.83% | 88,491 | 140.84M |
| 271 | XRAY | DENTSPLY SIRONA Inc. | 1.86B | -1.68% | 1,145,992 | 3.58B |
| 272 | LMAT | LeMaitre Vascular, Inc. | 1.83B | -1.28% | 18,533 | 269.36M |
| 273 | CERT | Certara, Inc. | 1.83B | -1.68% | 425,056 | 425.76M |
| 274 | MESO | Mesoblast Limited | 1.82B | -2.22% | 23,372 | 120.25M |
| 275 | INSP | Inspire Medical Systems, Inc. | 1.82B | -2.11% | 26,809 | 880.94M |
| 276 | GENB | Generate Biomedicines, Inc. | 1.82B | -0.14% | 129,549 | 26.48M |
| 277 | ABSI | Absci Corporation | 1.82B | -2.04% | 473,216 | 1.56M |
| 278 | STOK | Stoke Therapeutics, Inc. | 1.80B | -0.65% | 143,685 | 28.21M |
| 279 | BFLY | Butterfly Network, Inc. | 1.79B | 0.60% | 661,544 | 123.26M |
| 280 | SRPT | Sarepta Therapeutics, Inc. | 1.79B | -2.96% | 355,269 | 1.96B |
| 281 | NRIX | Nurix Therapeutics, Inc. | 1.79B | 1.30% | 719,812 | 701.94M |
| 282 | KMTS | Kestra Medical Technologies, Ltd. | 1.77B | -1.23% | 22,592 | 106.73M |
| 283 | AZTA | Azenta, Inc. | 1.76B | -1.98% | 52,803 | 613.81M |
| 284 | ALVO | Alvotech | 1.74B | 3.84% | 179,856 | 494.61M |
| 285 | NVAX | Novavax, Inc. | 1.73B | -3.67% | 1,613,560 | 411.65M |
| 286 | LYCA | Lycia Therapeutics, Inc. | 1.73B | -1.19% | 32,318 | 4.44M |
| 287 | PSNL | Personalis, Inc. | 1.73B | -0.06% | 809,410 | 80.77M |
| 288 | SLS | SELLAS Life Sciences Group, Inc. | 1.71B | -1.28% | 1,268,493 | - |
| 289 | NBTX | Nanobiotix S.A. | 1.66B | 2.15% | 2,223 | 13.15M |
| 290 | HCSG | Healthcare Services Group, Inc. | 1.65B | -1.53% | 50,748 | 1.88B |
| 291 | PGEN | Precigen, Inc. | 1.64B | -3.17% | 1,095,334 | 156.94M |
| 292 | IMCR | Immunocore Holdings plc | 1.64B | -0.13% | 69,649 | 429.30M |
| 293 | ASTH | Astrana Health, Inc. | 1.63B | -5.57% | 46,212 | 3.91B |
| 294 | WGS | GeneDx Holdings Corp. | 1.63B | -16.71% | 1,324,355 | 460.78M |
| 295 | QURE | uniQure N.V. | 1.63B | 1.84% | 222,765 | 20.17M |
| 296 | OMCL | Omnicell, Inc. | 1.63B | -5.25% | 105,074 | 1.24B |
| 297 | RARE | Ultragenyx Pharmaceutical Inc. | 1.62B | -2.86% | 291,505 | 730.00M |
| 298 | ENOV | Enovis Corporation | 1.60B | -2.66% | 101,153 | 2.31B |
| 299 | NTLA | Intellia Therapeutics, Inc. | 1.59B | -6.19% | 851,856 | 52.89M |
| 300 | SNDA | Sonida Senior Living, Inc. | 1.59B | -1.11% | 46,476 | 593.56M |
| 301 | BRVE | Braveheart Bio, Inc. | 1.57B | -1.08% | 10,316 | - |
| 302 | ADRX | ADARx Pharmaceuticals, Inc. | 1.57B | 1.38% | 31,301 | 6.13M |
| 303 | TDOC | Teladoc Health, Inc. | 1.56B | -4.79% | 843,816 | 2.47B |
| 304 | GPCR | Structure Therapeutics Inc. | 1.55B | 1.73% | 294,060 | - |
| 305 | RAPP | Rapport Therapeutics, Inc. | 1.55B | 0.19% | 85,201 | 20.00M |
| 306 | DMRA | Damora Therapeutics, Inc. | 1.50B | 0.87% | 30,092 | - |
| 307 | ALHC | Alignment Healthcare, Inc. | 1.50B | -1.44% | 351,045 | 4.94B |
| 308 | CNMD | CONMED Corporation | 1.50B | -3.14% | 18,094 | 1.37B |
| 309 | TYRA | Tyra Biosciences, Inc. | 1.50B | -2.42% | 82,523 | - |
| 310 | NUVB | Nuvation Bio Inc. | 1.49B | -3.22% | 510,743 | 201.73M |
| 311 | OCUL | Ocular Therapeutix, Inc. | 1.48B | -2.04% | 502,538 | 50.38M |
| 312 | NVCR | NovoCure Limited | 1.47B | 0.20% | 222,901 | 725.39M |
| 313 | PCRX | Pacira BioSciences, Inc. | 1.46B | 0.07% | 106,891 | 743.30M |
| 314 | ANIP | ANI Pharmaceuticals, Inc. | 1.46B | 1.40% | 744,609 | 1.04B |
| 315 | USPH | U.S. Physical Therapy, Inc. | 1.45B | -2.40% | 27,921 | 829.86M |
| 316 | LBRX | LB Pharmaceuticals Inc | 1.45B | -0.78% | 33,191 | - |
| 317 | AMN | AMN Healthcare Services, Inc. | 1.43B | -1.47% | 82,121 | 3.52B |
| 318 | KARD | Kardigan, Inc. | 1.43B | 0.86% | 322,056 | - |
| 319 | ANAB | AnaptysBio, Inc. | 1.43B | -0.21% | 13,323 | 106.09M |
| 320 | AAPG | Ascentage Pharma Group International | 1.42B | 1.11% | 923 | 94.61M |
| 321 | PAHC | Phibro Animal Health Corporation | 1.40B | -0.03% | 7,846 | 1.54B |
| 322 | TSHA | Taysha Gene Therapies, Inc. | 1.40B | -1.72% | 313,110 | 5.49M |
| 323 | MLYS | Mineralys Therapeutics, Inc. | 1.39B | -0.70% | 193,288 | - |
| 324 | KRSA | Korsana Biosciences, Inc. | 1.39B | -2.42% | 205,893 | - |
| 325 | INBX | Inhibrx Biosciences, Inc. | 1.35B | 0.10% | 14,386 | 1.30M |
| 326 | AVLN | Avalyn Pharma Inc. | 1.35B | 2.88% | 35,949 | - |
| 327 | INVA | Innoviva, Inc. | 1.34B | -0.47% | 69,740 | 438.32M |
| 328 | MNKD | MannKind Corporation | 1.33B | -1.67% | 392,358 | 413.37M |
| 329 | GHRS | GH Research PLC | 1.32B | -0.21% | 25,201 | - |
| 330 | NUTX | Nutex Health Inc. | 1.31B | -1.31% | 6,620 | 796.53M |
| 331 | LMRI | Lumexa Imaging Holdings, Inc. | 1.31B | -2.72% | 89,066 | 1.04B |
| 332 | PRCT | PROCEPT BioRobotics Corporation | 1.30B | 1.23% | 191,093 | 352.31M |
| 333 | CMPS | COMPASS Pathways plc | 1.30B | 0.11% | 501,199 | - |
| 334 | NKTR | Nektar Therapeutics | 1.30B | 0.33% | 58,992 | 54.59M |
| 335 | TNDM | Tandem Diabetes Care, Inc. | 1.29B | 2.04% | 393,188 | 1.08B |
| 336 | DRTS | Alpha Tau Medical Ltd. | 1.28B | -1.49% | 103,468 | - |
| 337 | CRON | Cronos Group Inc. | 1.28B | -2.26% | 319,597 | 206.20M |
| 338 | URGN | UroGen Pharma Ltd. | 1.28B | -0.84% | 112,638 | 250.25M |
| 339 | SVRA | Savara Inc. | 1.28B | -0.40% | 304,097 | - |
| 340 | OPK | OPKO Health, Inc. | 1.27B | 0.29% | 597,568 | 654.10M |
| 341 | PNTG | The Pennant Group, Inc. | 1.26B | -0.97% | 99,176 | 1.17B |
| 342 | OMER | Omeros Corporation | 1.26B | -0.91% | 109,046 | 38.42M |
| 343 | INNV | InnovAge Holding Corp. | 1.24B | -1.19% | 250,377 | 1.02B |
| 344 | SLN | Silence Therapeutics plc | 1.23B | - | 240,703 | 615.00K |
| 345 | AMPH | Amphastar Pharmaceuticals, Inc. | 1.22B | -2.42% | 55,839 | 745.79M |
| 346 | HROW | Harrow, Inc. | 1.22B | 18.38% | 1,053,711 | 303.25M |
| 347 | VOR | Vor Biopharma Inc. | 1.22B | -0.60% | 83,826 | - |
| 348 | STAA | STAAR Surgical Company | 1.21B | -1.79% | 356,672 | 328.27M |
| 349 | SGP | SpyGlass Pharma, Inc. | 1.20B | -6.18% | 19,385 | - |
| 350 | GDRX | GoodRx Holdings, Inc. | 1.20B | -3.56% | 310,097 | 785.23M |
| 351 | SPTX | Seaport Therapeutics, Inc. | 1.15B | -1.94% | 43,258 | - |
| 352 | FRNM | Freenome, Inc. | 1.14B | 0.76% | 89,540 | 35.41M |
| 353 | SIBN | SI-BONE, Inc. | 1.14B | -1.05% | 58,219 | 220.65M |
| 354 | IART | Integra LifeSciences Holdings Corporation | 1.13B | 0.77% | 243,839 | 1.66B |
| 355 | ATEC | Alphatec Holdings, Inc. | 1.10B | -3.73% | 441,310 | 839.72M |
| 356 | IRMD | IRADIMED CORPORATION | 1.10B | -0.86% | 5,758 | 89.34M |
| 357 | ANRO | Alto Neuroscience, Inc. | 1.10B | 0.43% | 77,233 | - |
| 358 | VSTM | Verastem, Inc. | 1.09B | -0.29% | 268,236 | 100.30M |
| 359 | MLTX | MoonLake Immunotherapeutics | 1.09B | 1.35% | 160,064 | - |
| 360 | CBLL | CeriBell, Inc. | 1.07B | -0.11% | 50,862 | 108.72M |
| 361 | CSTL | Castle Biosciences, Inc. | 1.06B | 0.29% | 60,212 | 377.13M |
| 362 | AHG | Akso Health Group | 1.03B | -6.25% | 5,576 | 13.83M |
| 363 | JBIO | Jade Biosciences, Inc. | 990.85M | -0.13% | 92,370 | - |
| 364 | AORT | Artivion, Inc. | 987.50M | -1.94% | 52,983 | 481.88M |
| 365 | AHCO | AdaptHealth Corp. | 976.55M | -0.54% | 103,883 | 3.44B |
| 366 | CTY | City Therapeutics, Inc. | 966.77M | 4.07% | 179,002 | 14.34M |
| 367 | CRVS | Corvus Pharmaceuticals, Inc. | 955.72M | -0.18% | 233,131 | - |
| 368 | ORIC | ORIC Pharmaceuticals, Inc. | 952.57M | -0.43% | 85,435 | - |
| 369 | AKTS | Aktis Oncology, Inc. | 931.63M | 2.32% | 52,637 | 10.06M |
| 370 | ODTX | Odyssey Therapeutics, Inc. | 928.62M | 1.15% | 39,745 | 99.00K |
| 371 | BVS | Bioventus Inc. | 923.50M | -0.50% | 91,841 | 585.64M |
| 372 | MGTX | MeiraGTx Holdings plc | 921.05M | 1.05% | 84,132 | 397.50M |
| 373 | BBNX | Beta Bionics, Inc. | 910.10M | -1.24% | 81,196 | 127.27M |
| 374 | GLUE | Monte Rosa Therapeutics, Inc. | 909.19M | 0.57% | 92,612 | 70.33M |
| 375 | PHAR | Pharming Group N.V. | 906.51M | -0.46% | 6,048 | 386.75M |
| 376 | OMDA | Omada Health, Inc. | 897.07M | -4.17% | 301,477 | 333.04M |
| 377 | IVA | Inventiva S.A. | 888.37M | 0.78% | 506,367 | 2.81M |
| 378 | KIDS | OrthoPediatrics Corp. | 885.41M | -0.24% | 68,774 | 264.14M |
| 379 | IMTX | Immatics N.V. | 881.65M | 0.31% | 222,039 | 47.65M |
| 380 | SNDX | Syndax Pharmaceuticals, Inc. | 875.97M | 1.88% | 321,122 | 289.68M |
| 381 | HSTM | HealthStream, Inc. | 870.28M | -1.53% | 17,294 | 327.95M |
| 382 | LTGO | Latigo Biotherapeutics, Inc. | 869.18M | -1.80% | 33,211 | - |
| 383 | BBTX | Bambusa Therapeutics, Inc. | 866.02M | 0.35% | 3,351 | - |
| 384 | LXRX | Lexicon Pharmaceuticals, Inc. | 854.85M | 5.49% | 900,605 | 38.54M |
| 385 | ALMS | Alumis Inc. | 840.03M | -0.92% | 168,762 | 7.40M |
| 386 | OBX | Obsidian Therapeutics, Inc. | 825.90M | -2.48% | 132,155 | - |
| 387 | GMRS | GMR Solutions Inc. | 825.40M | -5.77% | 807,570 | 5.97B |
| 388 | DNA | Ginkgo Bioworks Holdings, Inc. | 822.22M | -1.29% | 455,908 | 130.75M |
| 389 | QDEL | QuidelOrtho Corporation | 814.43M | -1.82% | 218,564 | 2.59B |
| 390 | RIGL | Rigel Pharmaceuticals, Inc. | 806.58M | 1.87% | 15,049 | 288.21M |
| 391 | ANNX | Annexon, Inc. | 804.76M | 0.35% | 580,460 | - |
| 392 | IRWD | Ironwood Pharmaceuticals, Inc. | 803.75M | 3.74% | 1,320,236 | 400.30M |
| 393 | AURA | Aura Biosciences, Inc. | 798.25M | 0.13% | 193,525 | - |
| 394 | SLDB | Solid Biosciences Inc. | 792.99M | 1.21% | 361,073 | - |
| 395 | PHR | Phreesia, Inc. | 787.37M | -1.67% | 38,127 | 507.79M |
| 396 | VREX | Varex Imaging Corporation | 777.21M | -0.05% | 56,097 | 865.00M |
| 397 | ATTO | Attovia Therapeutics, Inc. | 769.22M | 5.58% | 23,979 | 1.44M |
| 398 | OABI | OmniAb, Inc. | 764.31M | -1.13% | 271,709 | 40.21M |
| 399 | ABUS | Arbutus Biopharma Corporation | 760.72M | 3.36% | 354,426 | 181.49M |
| 400 | INMD | InMode Ltd. | 759.32M | -2.22% | 133,046 | 374.63M |
| 401 | CTKB | Cytek Biosciences, Inc. | 758.55M | -1.53% | 186,892 | 207.65M |
| 402 | DCTH | Delcath Systems, Inc. | 755.60M | 7.15% | 651,228 | 109.96M |
| 403 | SGMT | Sagimet Biosciences Inc. | 755.18M | -1.66% | 74,597 | - |
| 404 | FLGT | Fulgent Genetics, Inc. | 754.35M | 3.25% | 60,223 | 330.28M |
| 405 | COLL | Collegium Pharmaceutical, Inc. | 754.20M | -1.78% | 63,830 | 815.19M |
| 406 | CGEM | Cullinan Therapeutics, Inc. | 748.12M | -0.90% | 161,161 | - |
| 407 | ARDX | Ardelyx, Inc. | 746.58M | 1.37% | 1,234,096 | 468.22M |
| 408 | JANX | Janux Therapeutics, Inc. | 740.32M | -5.17% | 602,191 | 23.29M |
| 409 | SANA | Sana Biotechnology, Inc. | 734.11M | -0.61% | 523,247 | - |
| 410 | PACB | Pacific Biosciences of California, Inc. | 729.12M | -1.27% | 1,744,515 | 161.39M |
| 411 | CADL | Candel Therapeutics, Inc. | 728.46M | 0.32% | 122,434 | - |
| 412 | NVCT | Nuvectis Pharma, Inc. | 722.17M | -0.10% | 75,276 | - |
| 413 | PRME | Prime Medicine, Inc. | 713.40M | -6.74% | 742,866 | 4.07M |
| 414 | IMMX | Immix Biopharma, Inc. | 705.50M | -0.70% | 140,406 | - |
| 415 | AVBP | ArriVent BioPharma, Inc. | 702.88M | 0.67% | 228,126 | 5.00M |
| 416 | ZVRA | Zevra Therapeutics, Inc. | 696.20M | -3.62% | 263,239 | 147.76M |
| 417 | FDMT | 4D Molecular Therapeutics, Inc. | 695.52M | 0.88% | 108,350 | 92.01M |
| 418 | DBVT | DBV Technologies S.A. | 694.93M | 0.81% | 21,150 | 3.74M |
| 419 | IAM | Iambic Therapeutics, Inc. | 687.31M | 8.37% | 416,497 | 18.25M |
| 420 | DSGN | Design Therapeutics, Inc. | 687.11M | -0.65% | 23,534 | - |
| 421 | ANL | Adlai Nortye Group Ltd. | 685.19M | -4.57% | 60,668 | 18.06M |
| 422 | KURA | Kura Oncology, Inc. | 680.55M | 1.06% | 594,572 | 77.23M |
| 423 | WVE | Wave Life Sciences, Inc. | 680.44M | -0.86% | 296,225 | 70.92M |
| 424 | APMD | Apnimed, Inc. | 676.92M | 2.85% | 130,990 | 115.12M |
| 425 | CLYM | Climb Bio, Inc. | 676.66M | 4.63% | 232,558 | - |
| 426 | ACRS | Aclaris Therapeutics, Inc. | 670.93M | -0.24% | 291,024 | 6.40M |
| 427 | HELP | Helus Pharma Inc. | 665.58M | -2.77% | 105,878 | - |
| 428 | SOPH | SOPHiA GENETICS SA | 656.14M | 2.27% | 323,702 | 90.97M |
| 429 | OLMA | Olema Pharmaceuticals, Inc. | 653.61M | 1.49% | 214,931 | - |
| 430 | BCAX | Bicara Therapeutics Inc. | 651.47M | -1.35% | 194,406 | - |
| 431 | GERN | Geron Corporation | 640.37M | -0.25% | 3,582,287 | 217.52M |
| 432 | SENS | Senseonics Holdings, Inc. | 633.43M | 22.24% | 2,435,376 | 60.01M |
| 433 | EVO | Evotec SE | 614.90M | -2.30% | 66,621 | 815.72M |
| 434 | SGHT | Sight Sciences, Inc. | 599.98M | -1.95% | 65,116 | 88.40M |
| 435 | TCMD | Tactile Systems Technology, Inc. | 590.50M | -0.86% | 14,007 | 356.42M |
| 436 | SRZN | Surrozen, Inc. | 582.06M | 3.97% | 41,600 | 10.53M |
| 437 | AVR | Anteris Technologies Global Corp. | 582.04M | 0.51% | 129,241 | 2.24M |
| 438 | VALN | Valneva SE | 581.35M | 5.39% | 19,157 | 163.30M |
| 439 | CBIO | Crescent Biopharma, Inc. | 574.82M | -1.61% | 23,682 | 11.88M |
| 440 | NRC | NRC Health | 565.55M | -0.07% | 24,910 | 143.79M |
| 441 | ENTX | Entera Bio Ltd. | 561.77M | -0.62% | 28,910 | 42.00K |
| 442 | SLBT | SL Science Holding Limited | 556.04M | -0.34% | 1,342 | 3.27M |
| 443 | TKNO | Alpha Teknova, Inc. | 551.03M | 2.46% | 80,452 | 45.95M |
| 444 | CAPR | Capricor Therapeutics, Inc. | 549.41M | -4.06% | 1,330,292 | 11.13M |
| 445 | OVID | Ovid Therapeutics Inc. | 544.88M | -2.11% | 857,964 | 1.45M |
| 446 | MYGN | Myriad Genetics, Inc. | 543.88M | -1.22% | 179,017 | 803.60M |
| 447 | RCEL | AVITA Medical, Inc. | 529.78M | 0.06% | 117,212 | 84.68M |
| 448 | ETRA | Electra Therapeutics, Inc. | 529.75M | 2.68% | 22,397 | - |
| 449 | SRTA | Strata Critical Medical, Inc. | 527.88M | -2.31% | 199,440 | 280.76M |
| 450 | EVH | Evolent Health, Inc. | 523.68M | -1.70% | 459,392 | 2.34B |
| 451 | DMAC | DiaMedica Therapeutics Inc. | 518.23M | -0.41% | 28,767 | - |
| 452 | RGNX | REGENXBIO Inc. | 517.74M | -2.97% | 178,614 | 153.91M |
| 453 | NGNE | Neurogene Inc. | 511.89M | -1.62% | 101,763 | 925.00K |
| 454 | ANGO | AngioDynamics, Inc. | 508.44M | -0.25% | 31,559 | 325.38M |
| 455 | MNPR | Monopar Therapeutics Inc. | 496.43M | 0.28% | 27,266 | - |
| 456 | STTK | Shattuck Labs, Inc. | 491.90M | -3.21% | 154,300 | 1.00M |
| 457 | MDXG | MiMedx Group, Inc. | 491.77M | 1.51% | 126,023 | 303.73M |
| 458 | EPRX | Eupraxia Pharmaceuticals Inc. | 488.31M | 0.07% | 29,611 | - |
| 459 | GYRE | Gyre Therapeutics, Inc. | 488.15M | -4.09% | 28,793 | 110.06M |
| 460 | OCS | Oculis Holding AG | 482.74M | 0.77% | 28,235 | 1.12M |
| 461 | YDES | YD Bio Limited | 464.65M | -2.24% | 15,640 | 1.24M |
| 462 | EOLS | Evolus, Inc. | 452.73M | -2.01% | 5,152,459 | 325.47M |
| 463 | AQST | Aquestive Therapeutics, Inc. | 450.59M | 1.27% | 561,294 | 48.84M |
| 464 | KMDA | Kamada Ltd. | 448.36M | 4.67% | 101,156 | 196.87M |
| 465 | RLMD | Relmada Therapeutics, Inc. | 446.95M | 1.21% | 149,194 | - |
| 466 | INDP | Indaptus Therapeutics, Inc. | 445.39M | -7.35% | 153,599 | - |
| 467 | BLSM | BlossomHill Therapeutics, Inc. | 444.67M | -3.25% | 33,892 | - |
| 468 | SI | Shoulder Innovations, Inc. | 442.51M | -1.44% | 20,111 | 64.49M |
| 469 | NPCE | NeuroPace, Inc. | 442.44M | -1.75% | 13,987 | 106.99M |
| 470 | TECX | Tectonic Therapeutic, Inc. | 442.40M | 3.38% | 52,550 | - |
| 471 | PRTA | Prothena Corporation plc | 442.12M | -1.88% | 71,752 | 52.74M |
| 472 | OBIO | Orchestra BioMed Holdings, Inc. | 441.90M | 1.40% | 58,125 | 31.98M |
| 473 | ARVN | Arvinas, Inc. | 436.13M | -1.48% | 75,212 | 275.30M |
| 474 | RZLT | Rezolute, Inc. | 434.30M | 6.98% | 224,593 | - |
| 475 | ASMB | Assembly Biosciences, Inc. | 433.48M | -2.29% | 19,186 | 74.85M |
| 476 | CTMX | CytomX Therapeutics, Inc. | 429.47M | -0.51% | 5,536,681 | 14.03M |
| 477 | MASS | 908 Devices Inc. | 429.04M | -9.82% | 59,742 | 65.79M |
| 478 | PHAT | Phathom Pharmaceuticals, Inc. | 428.53M | 1.22% | 79,407 | 274.88M |
| 479 | PBYI | Puma Biotechnology, Inc. | 426.90M | -1.49% | 46,766 | 231.87M |
| 480 | CTEV | Claritev Corporation | 426.70M | 4.12% | 172,287 | 1.02B |
| 481 | CRMD | CorMedix Inc. | 424.41M | -0.46% | 562,242 | 462.25M |
| 482 | STLN | Starling Oncology, Inc. | 424.28M | 4.00% | 1,388,186 | 620.45M |
| 483 | AVTX | Avalo Therapeutics, Inc. | 422.69M | 0.55% | 2,621,363 | 59.00K |
| 484 | CARL | Carlsmed, Inc. | 420.46M | -4.05% | 12,832 | 63.30M |
| 485 | MPLT | MapLight Therapeutics, Inc. | 420.15M | 3.85% | 67,957 | - |
| 486 | BWAY | BrainsWay Ltd. | 420.08M | -9.71% | 163,916 | 60.70M |
| 487 | CERS | Cerus Corporation | 414.01M | -0.97% | 198,133 | 226.57M |
| 488 | PEPG | PepGen Inc. | 413.48M | 149.79% | 71,539,937 | - |
| 489 | CTNM | Contineum Therapeutics, Inc. | 402.87M | -0.39% | 55,355 | - |
| 490 | CCCC | C4 Therapeutics, Inc. | 401.83M | -2.86% | 209,679 | 32.28M |
| 491 | MOBI | Mobia Medical, Inc. | 399.93M | -2.12% | 18,607 | 51.89M |
| 492 | ALT | Altimmune, Inc. | 395.84M | -4.01% | 863,877 | 31.00K |
| 493 | LYEL | Lyell Immunopharma, Inc. | 393.86M | 3.89% | 41,920 | 15.00K |
| 494 | TLRY | Tilray Brands, Inc. | 393.06M | -5.96% | 1,229,485 | 963.10M |
| 495 | EDIT | Editas Medicine, Inc. | 390.09M | -7.64% | 631,460 | 49.83M |
| 496 | PRLD | Prelude Therapeutics Incorporated | 380.05M | -1.86% | 25,048 | 22.42M |
| 497 | DTIL | Precision BioSciences, Inc. | 374.84M | 1.45% | 82,707 | 45.04M |
| 498 | TRXB | TRex Bio, Inc. | 367.75M | 0.52% | 30,794 | - |
| 499 | FENC | Fennec Pharmaceuticals Inc. | 367.50M | -3.23% | 38,975 | 59.22M |
| 500 | AGMB | AgomAb Therapeutics NV | 364.93M | -1.85% | 11,485 | - |